Cargando…
Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP
BACKGROUND: Cisplatin is the standard first‐line chemotherapeutic agent for the treatment of non‐small cell lung cancer (NSCLC). However, resistance to chemotherapy has been a major obstacle in the management of NSCLC. Aldehyde dehydrogenase 1A1 (ALDH1A1) overexpression has been observed in a variet...
Autores principales: | Wei, Yunyan, Wu, Shuangshuang, Xu, Wei, Liang, Yan, Li, Yue, Zhao, Weihong, Wu, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217899/ https://www.ncbi.nlm.nih.gov/pubmed/27813328 http://dx.doi.org/10.1111/1759-7714.12400 |
Ejemplares similares
-
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer
por: Shen, Jia-Xin, et al.
Publicado: (2016) -
Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma
por: Yang, Cheng–kun, et al.
Publicado: (2017) -
The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017) -
Salivary Aldehyde Dehydrogenase: Activity towards Aromatic Aldehydes and Comparison with Recombinant ALDH3A1
por: Giebułtowicz, Joanna, et al.
Publicado: (2009) -
The roles of aldehyde dehydrogenases (ALDHs) in the PDH bypass of Arabidopsis
por: Wei, Yanling, et al.
Publicado: (2009)